Buscar resultados de ensayos clínicos
Adenoma, Islet Cell - 110 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Efficacy and Safety of Everolimus and (STZ-5FU) Given One Upfront the Other Upon Progression in Advanced pNET Condición: Pancreatic Neuroendocrine Tumours. Fecha: 2014-08-20 Intervenciones:
|
Completed |
Nombre del estudio: Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms Condición: Pancreatic Neuroendocrine Tumors Fecha: 2014-04-26 Intervenciones:
|
Enrolling by invitation |
Nombre del estudio: Gastroenteral-Pancreatic Neuroendocrine Tumors in Taiwan Condición: This Study Plans to Include 600 GEP-NET Patients. Fecha: 2014-02-27 |
Active, not recruiting |
Nombre del estudio: EUS-guided Ethanol-lipiodol Ablation of Pancreatic Neuroendocrine Tumor: a Prospective Study Condición:
Fecha: 2013-07-15 Intervenciones: Procedure: EUS-guided ethanol-lipiodol mixture ablation By using 3D-volumetric analysis, the optimal vol |
Completed |
Nombre del estudio: Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor Condición: Advanced Well-differentiated Pancreatic Neuroendocrine Tumor Fecha: 2013-04-29 Intervenciones: Drug: temozolomide or dacarbazine-based chemotherapy, endostatin |
Completed |
Nombre del estudio: 68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours Condición: Neuroendocrine Tumours Fecha: 2012-08-09 Intervenciones: Drug: Diagnostic work up Patients will undergo MDCT, PET and EUS. Every attempt will be made to achieve |
Completed |
Nombre del estudio: BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy. Condición: Pancreatic Neuroendocrine Tumors (pNET) Fecha: 2012-07-06 Intervenciones: Drug: BEZ235 (Stage 1) The investigational study drug used in this trial was BEZ235, which was supplied |
Terminated |
Nombre del estudio: Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors Condición: Pancreatic Neuroendocrine Tumors (pNET) Fecha: 2012-06-25 Intervenciones:
|
Recruiting |
Nombre del estudio: Potential Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine Tumors Condición: Pancreatic Neuroendocrine Cancer Fecha: 2012-05-16 Intervenciones: Other: MRI Patients will be treated with either sunitinib, everolimus, or traditional chemotherapy accor |
Active, not recruiting |
Nombre del estudio: A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors Condición: Well-differentiated Pancreatic Neuroendocrine Tumor Fecha: 2012-01-13 Intervenciones: Drug: sunitinib Sunitinib capsules will be given orally at continuous daily dosing with a starting dose |